| Financial Year |
March 31 2023 |
| Monetary Funds |
1,664,533,189.09 |
| Held-for-trading Financial Assets |
474,486,119.36 |
| Notes Receivable |
209,771,919.26 |
| Accounts Receivable |
1,118,535,440.89 |
| Advances to Suppliers |
314,893,845.69 |
| Other Receivables |
65,809,227.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,763,970,826.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,908,644.01 |
| Total Current Assets |
8,063,993,513.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
868,812,555.48 |
| Investment Properties |
40,220,662.74 |
| Fixed Assetes |
1,474,290,390.17 |
| Under-construction Projects |
79,637,441.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
589,728,224.19 |
| R&D expenses |
161,256,379.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,949,792.40 |
| Deferred Income Tax Assets |
155,476,805.46 |
| Other Non-Current Assets |
37,187,665.72 |
| Sub-Total of Non-Current Assets |
3,851,194,706.37 |
| Total Assets |
11,915,188,219.63 |
| Short-Term Loans |
648,274,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
454,724,822.84 |
| Accounts Payable |
1,645,687,592.97 |
| Accounts Received In Advance |
77,101.60 |
| Employee Compensation Payable |
5,067,090.76 |
| Taxes Payable |
9,544,880.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,952,560.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,203,084,683.14 |
| Other Current Liabilities |
106,853,234.56 |
| Sub-Total of Current Liabilities |
6,703,091,264.33 |
| Long-term Loans |
530,959,677.71 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
237,605.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
891,021,273.92 |
| Total Liabilities |
7,594,112,538.25 |
| Paid-In Capital(Or Share Stock) |
1,550,211,950.00 |
| Capital Surplus |
2,574,659,632.20 |
| Surplus Reserve |
193,818,424.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-118,316,067.77 |
| Minority Stockholder's Interest |
106,935,184.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,214,140,496.73 |
| Owner's Equity（Stockholder's Equity） |
4,321,075,681.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,915,188,219.63 |
